Photofrin II-based photosensitization of human ovarian clear-cell carcinoma cell line (OvBH-1)

Pharmacological Reports

Volumn 59, Issue SUPPL. 1, 2007, Pages 150-160

  Bar, Julia K ^a   Saczko, Jolanta ^a   Ziółkowski, Piotr ^a   Chwiłkowska, Agnieszka ^a   Słomska, Iwona ^a   Zalesińska, Małgorzata Drag ^a   Wysocka, Teresa ^a   Duś, Danuta ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Apoptosis; MCF 7 cell lines; Necrosis; OvBH 1; PDT

Indexed keywords

CYTOKERATIN 18; MITOCHONDRIAL ENZYME; PHOTOFRIN II; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL NUCLEUS; CELL STRAIN MCF 7; CELL STRUCTURE; CLEAR CELL CARCINOMA; COMET ASSAY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; STATISTICAL SIGNIFICANCE;

EID: 38049177896     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Almeida RD, Manandas BJ, Carvalho AP, Duarte CB: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta, 2004, 1704, 59-86.
2. Ashby J, Tinwell H, Lefevre PA, Browne MA: The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. Mutagenesis, 1995, 10, 85-90.
3. Bantel H, Ruck P, Gregor M, Schulze-Osthoff K: Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol, 2001, 80, 230-239.
4. Bar JK, Harłozińska A, Kartarius S, Montenarh M, Wyrodek E, Rodriguez P et al.: Temperature-sensitive ovarian carcinoma cell line (OvBH-1). Jpn Cancer Res, 2002, 93, 976-985.
5. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B et al.: Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Nat Cancer Inst, 2005, 20, 1516-1524.
6. Dolmans DE, Fukumura D, Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer, 2003, 5, 380-387.
7. Dougherty Th, Gomer Ch, Henderson B, Jori G, Kessel D, Korbelik M, Moan J et al.: Photodynamic therapy. J Nat Cancer Inst, 1998, 12, 889-901.
8. Duska LR, Hamblin MR, Miller JL, Hasan T: Combination of photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Nat Cancer Inst, 1999, 18, 1557-1563.
9. Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res, 1978, 38, 4327-4339.
10. Fischer AM, Rucker N, Wong S, Gomer CJ: Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines. J Photochem Photobiol, 1998, 42, 104-107.
11. Fischer AMIR, Ferrario A, Rucker N, Zhang S. Gomer CJ: Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function. Cancer. Res, 1999, 59, 331-335.
12. Hahn SM, Put ME, Shin DB, Ricter E, Menon C, Smith D, Glastetin E et al. Photoftin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy for patients with intraperitoneal photodynamic therapy. Clin Cancer Res, 2006, 15, 12, 5464-5470.
13. Johnstone RW, Ruefli AA, Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell, 2002, 108, 153-164.
14. Kelland LR: Overcoming resistance to platinum therapy in patients with advanced cancer. Am J Cancer, 2002, 1, 247-255.
15. Leers MP. Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Börklund P et al.: Immunohistochemical detection and localization of a cytokeratin 18 epitope exposed during early apoptosis. J Pathol, 1999, 187, 567-572.
16. Luksiene Z: Photodynamic therapy: mechanism of action. and ways to improve the efficiency of treatment. Medicina, 2003, 12, 1137-1150.
17. Nakayama K, Takebayashi Y, Nakayama S, Hata K, Fujiwaki R, Fukumoto M, Miyazaki K: Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin. Cancer Lett, 2003, 192, 227-235.
18. Ohta I, Gorai I, Miyamoto Y, Yang J, Zheng JH, Kawata N, Hirahura F et al.: Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells. Cancer Lett, 2001, 162, 39-48.
19. Oleinick NL, Morris RL, Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci, 2003, 1, 1-21.
20. Olive PL: Comet assay - an overview of techniques. Methods Mol Biol, 2002,203, 179-194.
21. Oren M: Decision making by p53: life, death and cancer. Cell Death Differentiation, 2003, 10, 431-442.
22. Red JC: Double identity for proteins of Bcl-2 family. Nature, 1997, 387, 773-776.
23. Rózalski M, Mirowski M, Balcerzak E, Krajewska U, Młynarski W, Wierzbicki R: Induction of caspase 3 activity, bcl-2 bax. and p65 gene expression modulation in human acute promyelocyfic leukemia HL-60 cells by doxorubicin with amifosfotine. Pharmacol Rep, 2005, 57, 360-366.
24. Shen XY, Zacal N, Singh G, Rainbow AJ: Alternations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Pliotobiol,. 2005, 81, 306-313.
25. Siddik ZH, Mims B, Guillermina M, Thai G: Independent pathways of p53 induction ky cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line. Cancer Res, 1998, 58, 698-703.
26. Song K, Kong B, Qu X, Li L, Yang Q: Phototoxicty of hemoporfin to ovarian cancer. Biochem Biophysi Res Commun, 2005, 337, 127-132.
27. Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikucha Y, Kita T, Suzuki M et al.: Clinical characteristics of clear cell caricinoma of the ovary. Cancer, 2000, 88, 2584-2589.
28. Tong Z, Singh G, Rainbow AJ: The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy. Photochem Photobiol, 2000, 71, 201-210.
29. Vousden KH, Lu X: Live or let die: the cell's response to p53. Nat Rev Cancer, 2002, 2, 594-604.
30. Wong T-W, Tracy E, Oseroff AR, Baumann H: Photodynamic therapy mediates immediate loss of cellular reponsiveness to cytokines and growth factors. Cancer Res, 2003, 63, 3812-3818.
31. Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG, Boothman DA: Induction of apoptosis in MCF-7: WS8 breast cancer cells by beta-lapachone. Cancer Res, 1998, 55, 1876-1885.
32. Zhang WG, Li XW, Ma LP, Wang SW, Yang HY, Zhang ZY: Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53. Cancer Lett, 1999, 138, 189-195.